BARDA DRIVe ImmuneChip+ (through
Supports creators of immune-enabled organ-on-chip systems and biosensing manufacturing for critical health technology challenges.
The BARDA DRIVe ImmuneChip+ program is an open Broad Agency Announcement (BAA) administered by the Biomedical Advanced Research and Development Authority's Division of Research, Innovation, and Ventures, accepting proposals on a rolling basis through September 28, 2028. The program funds advanced in vitro microphysiological systems — commonly known as organ-on-chip platforms — that incorporate imm…
Advanced in vitro microphysiological systems incorporating immune components — including organ-on-chip platforms with automated manufacturing, biosensors, and multi-tissue integration — for CBRN medical countermeasure development.
Sign up free to see the funding breakdown
Sign up free to see the industries in scope
Sign up free to see the full eligibility
Sign up free to see the timeline
Guides for this application
All guides →Grants for Biotech Startups: NIH, NSF, SBIR/STTR, and Non-Dilutive Funding
A practical guide to grants for biotech startups, including NIH SBIR/STTR, NSF, translational funding, evidence, regulatory readiness, and budgets.
Submit & reportSAM.gov Registration and UEI Guide for Federal Grant Applicants
Learn how SAM.gov registration, UEI numbers, Grants.gov accounts, organization profiles, workspace roles, and renewal timing fit together.
BudgetIndirect Costs in Grants: Rates, MTDC, and Examples
Understand indirect costs in grants, including direct vs indirect costs, negotiated rates, de minimis rates, MTDC, funder caps, and budget narrative implications.
More from BARDA
All grants from this funder →BARDA BAA (through
🇺🇸BARDA · United States
Supports teams developing countermeasure technologies for CBRN, diagnostics, and readiness-focused therapeutics through BARDA BAA.
Project BioShield Procurement
🇺🇸BARDA · United States
Administers late-stage medical countermeasure development with United States government procurement pathways for strategic stockpile readiness.
BARDA Accelerator Network — POC Funding
🇺🇸BARDA · United States
Funds proof-of-concept medical countermeasure projects across diagnostics, digital health, and therapeutic platforms.
BARDA Accelerator Network — Proof-of-Concept Funding
🇺🇸BARDA · United States
Supports United States health-security teams with early milestone-based funding for proof-of-concept countermeasure work.
BARDA RRPV — Member
🇺🇸BARDA · United States
Supports members of dedicated consortiums to pursue medical countermeasure proposals through BARDA rapid response partnership pathways.
BARDA Ventures — Equity Co-Investment
BARDA · United States
Invests in healthcare-focused countermeasure enterprises through BARDA Ventures, advancing diagnostics, vaccines, and resilient production growth stages.
Similar grants
Browse the directory →
Cancer Grand Challenges
🇺🇸NCI · United States
Supports large interdisciplinary global teams tackling transformative unsolved problems in cancer biology.
NIMHD SBIR Phase IIB Strategic Breakthrough Award
🇺🇸NIMHD · United States
Funds prior NIH SBIR and STTR Phase II small businesses bridging later-stage R&D to commercialization.
NIAMS STTR — Small Business Technology Transfer
🇺🇸NIAMS · United States
Supports small businesses partnering with research institutions on arthritis and musculoskeletal science.
R&D Tax Credit — Income Tax Credit (Section 41) — TY2025 / Filed
🇺🇸IRS · United States
Supports established United States companies with income tax credits tied to qualified innovation spending.
DARPA ERIS (Expedited Research Implementation Series)
🇺🇸DARPA · United States
Backs research teams and institutions for DARPA ERIS in defense innovation, biotechnology, and medical technology.
ARPA-H Initiatives & Sprints
🇺🇸ARPA-H · United States
Runs fast-turnaround health technology opportunities in United States for high-potential exploratory science and engineering.